This month I’m featuring an innovative software company with an AI angle.

While AI is all the rage, bordering on hype, this company’s learning platform has been harnessing the technology for a few years. The latest iterations of AI are likely to help make its product better and open new monetization opportunities.

It’s a neat story and the company has terrific products that are loved by users. Because of the recent run in tech stocks, we’ll start with a half-sized position. Enjoy!

The market still has many of the same issues that have been hanging around for weeks, including an extreme narrowness, with the vast majority of the market struggling while mega-cap indexes do pretty well. Even so, we do think the evidence has taken a step in the right direction -- the AI boomlet is a positive sign, and many non-AI leaders acted well in May and have rested normally since. We’re not flooring the accelerator, but given our monstrous cash position, we’re dropping a couple more lines in the water tonight, adding two half-sized stakes in old favorites.

Elsewhere in tonight’s issue, we give our thoughts (and some ideas) within the AI advance, write about a long-term growth area that could be re-emerging and, as always, go over our stocks, an expanded watch list and some other new ideas to chew on.

It was another good week for Explorer recommendations led by ChargePoint (CHPT), up 17%, and Butterfly (BFLY), up another 8%.


Some of you will remember when George Gilder’s Wealth and Poverty hit the market in 1981 like a thunderclap. It was intellectual capital and political firepower for both the Reagan Revolution and a big bull market.



Mr. Gilder has been active ever since and has a new book out that I highly recommend, Life After Capitalism.

Now that Florida Gov. Ron DeSantis (R) is officially in the race for the Republican presidential nomination, it’s worth knowing more about his views on cannabis policy.


After all, DeSantis will now play an even bigger part in the election debates, even if polls say DeSantis has a slim chance against frontrunner Donald Trump. His voice matters – since cannabis is such a politically driven sector.



The bottom line: DeSantis offers a mixed picture, but it’s not all bad for cannabis investors.

Despite a couple concerning days to start the week, the bulls took control on Thursday and Friday as tech titan Nvidia’s (NVDA) earnings blowout triggered a “risk-on” bull run.

Thank you for subscribing to the Cabot Turnaround Letter. We hope you enjoy reading the June 2023 issue.

It’s no secret that a fresh fascination with artificial intelligence has ignited shares of companies like Alphabet (GOOG), Microsoft (MSFT) and Nvidia (NVDA), while “safety stocks” like Apple (AAPL) have rebounded on recession fears. Shares of more prosaic technology companies have lagged, but a few offer highly relevant albeit slow-growth products and services, making their businesses highly resilient. They are often well-supported by durable balance sheets and capable management. We highlight four such companies.

As a follow-up to our April edition that featured banks, we have found additional interesting financial stocks by looking at the 13F filings of like-minded value investors. We discuss three that saw sizeable new purchases or meaningful additions to already-sizeable holdings by well-respected value managers.

Our feature recommendation this month is Tyson Foods (TSN), a major producer of chicken, beef and pork products. Its earnings and shares have tumbled due to an unusual simultaneous downturn in all three protein groups. The hardest time to buy a commodity cyclical is at the bottom of the cycle, as there appears to be no end in sight to the malaise. We think this is the time to buy Tyson.

For the first time in a while we started to see big investors floor the accelerator last week, with some names really letting loose on the upside. Moreover, even the “non-AI” nascent leaders that perked up earlier in May are acting fine, with most digesting gains in normal fashion. All of that is to the good—though the top-down flaws that we’ve written about are all still out there, too, with relatively few stocks hitting new highs, a good number of blowups each week and most areas of the market still struggling. Right now, we’re keeping our Market Monitor at a level 5, but we’re watching things closely—if more leaders emerge, it would certainly add to the bullish side of the ledger.

This week’s list has a bunch of solid growth and earnings-related plays from a variety of industries. Our Top Pick is practically a blue chip name from the software field that’s emerging from a solid launching pad.

A debt ceiling deal appears imminent, though that’s ultimately up to our ever-dysfunctional Congress. If it does get done, another Fed interest rate hike may be right behind it. So, the long-awaited rally may be on hold a while longer. But that doesn’t mean individual stocks (see artificial intelligence and semiconductors) can’t get a move-on, so today we add a small-cap MedTech stock that’s showing a lot of promise in addressing a very common – and thus very lucrative – health problem. It’s a new recommendation from Cabot Early Opportunities Chief Analyst Tyler Laundon.

We decided to take off our SPY June 16, 2023 430/435 bear call spread for a nice profit last week which marked 29 out of 33 winning trades since we started Quant Trader exactly one year ago. Moreover, our total return is now hovering around its highest point at 150%.

After locking in 10.8% in Wells Fargo (WFC) at the May 19, 2023, expiration cycle, we decided to sell more puts in WFC during the middle of last week. Since we are early in the trade in WFC, and thus there’s not much to discuss, there will be no comments on the current status of the trade below. Our total return since initiating the Income Trader service just under one year ago stands at 90.8%.

With earnings season behind and few earnings announcements scheduled for the week ahead, the only announcement worth a look this week is Lululemon (LULU). Even so, I wouldn’t be surprised to see no trades this week. This does not mean that we will not have a trade alert or two as we move into the earnings doldrums for the next several weeks.

Despite a couple concerning days to start the week, the bulls took control on Thursday and Friday as tech titan Nvidia’s (NVDA) earnings blowout triggered a “risk-on” bull run.

Earlier this week, we moved shares of a consumer staples company from Buy to Sell. We comment on earnings from two recommended stocks and comment on other recommended names. Some thoughts on the ESG trend.

The volatility continues but we’ve seen most of our stocks hold above previous lows (so far). The S&P 600 Small Cap Index is also holding above its lows from last week.

The markets continue to be challenging to say the least, with the S&P 500 off 18% so far this year, but like everyone I see some amazing companies posting strong numbers being pulled down over a blend of macro issues. These range from inflation and interest rates to the slowdown in China and conflict in Ukraine. Current Explorer recommendations still managed to outperform the market, with some up and most holding their ground in the past week. SQM (SQM) of Chile reported first-quarter profits up 10X over 2021.

The market has rallied strongly off last week’s lows. Buy I’m not buying into it. Stocks are already floundering badly again today.
The S&P 500 came to within close to 1% of a bear market last week, down 20% from the high on a closing basis before several up days and a better than 4% rally off the low. The index has posted six consecutive weeks of decline, the longest such streak in more than a decade.

The market has improved from the heavy selling of last week. But I’m not buying this rally just yet.

At the low point of the selling last week, the S&P 500 was down about 19% from the high. That was dangerously close to a bear market, down 20% from the high on a closing basis. A bear market is an important psychological level that would likely prompt further selling if crossed. And we came right up to the cusp.

The past couple of weeks in the market have not been fun.

The only fun thing about the last few weeks has been the weather.



We got into the 80s last week near Boston, and this weekend temperatures are likely to hit 90 degrees!



I even got to play my first round of golf and didn’t play too badly.

The financial press is full of chatter about what to do in the current market downturn. Common themes include timing the bottom (which usually includes the opposing suggestions to not time the markets followed by suggestions on how to do it), buying on the dips (highlighting the appeal vs. the danger that this is a secular bear market), and buying stocks that have been beaten down by 50% or more year-to-date. There are other themes, but these are the ones I see most often.

Despite the broad market downturn, all our portfolios are currently positioned to withstand the gyrations.

The S&P 500 rebounded 2.39% Friday while the Nasdaq jumped 3.82%. That kind of strong action clearly indicates that institutions such as hedge funds or mutual funds are scooping up shares.



The reason doesn’t matter, so it’s best not to try to explain the action away with theories such as short covering or an equity-buying spree in response to a (perhaps) peak in Treasury yields. It can be mentally entertaining to speculate or overthink these possibilities, but ultimately, it’s all about watching the charts.

You’ve often heard me say that gold’s biggest gains are normally made when investors are worried about either the stock market, the economy or the geopolitical outlook. Right now, all three of those outlooks are in serious question. Why, then, has gold failed to respond to the heightened fears?

This week’s Friday Update includes our comments on earnings reports from four companies and more color on our initial review of another company that reported last week. If Hollywood makes a movie about this market cycle, perhaps it will be called “Revenge of the Moat.”

There is no shortage of data pointing to just how bad this market is. With year-to-date (YTD) performance for the S&P 500, Nasdaq and S&P 600 of -17%, -27% and -18%, respectively, this is one of the worst YTD starts in decades.

The market is down again today, though we do see many stocks and some growth funds putting up a fight. As of 1:30 ET, the Dow is down 333 points and the Nasdaq is down 82 points, though growth funds are up in the 1% to 4% range.

This medical diagnostics company has a habit of being underestimated by Wall Street. The company beat earnings estimates by $0.58 in the last quarter.

This energy company is forecast to grow at an annual rate of 56.96% over the next five years. Its current annual dividend yield is 1.89%, paid quarterly.

The earnings of this biotech company are forecasted to grow by 49.3% next year.

This financial services company reported record revenue, net income, and earnings per share for the first nine months of the year.

Our warrants for LiCycle (LICY.WS) are being redeemed by the company.

This software company just posted a 43% increase in quarterly revenue, and Jim Cramer has recently recommended it.

Last Friday the Goodyear Tire (GT) December 23 call that we sold in late November for $1.17 expired worthless, leaving us with a stock position, and without a new call sale.

Aluminum prices have risen almost 8% in the past week as the global supply situation continues to tighten.

In the past 30 days, 20 analysts have raised their EPS targets on this tech stock.

Aspen Aerogels (ASPN) triggered our sell-stop. Let’s take our profits and sell today.

Although this mining company falls into the category of speculative stocks, analysts expect the company’s earnings to grow at an annual rate of 20% over the next five years.

This home building retailer beat analysts’ earnings estimates by $0.52 last quarter, and 33 analysts have recently increased their EPS forecasts for the company.

Our Cabot Top Ten Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Top Ten features.